Legal Research AI

United States v. Herrera

Court: Court of Appeals for the Tenth Circuit
Date filed: 2007-04-04
Citations: 481 F.3d 1266
Copy Citations
17 Citing Cases

                                                                      F I L E D
                                                               United States Court of Appeals
                                                                       Tenth Circuit
                                    PUBLISH
                                                                      April 4, 2007
                   UNITED STATES CO URT O F APPEALS               Elisabeth A. Shumaker
                                                                      Clerk of Court
                                 TENTH CIRCUIT



 U N ITED STA TES O F A M ER ICA,

             Plaintiff-Appellee,
       v.                                               No. 05-2219
 G ILBER T H ER RER A,

             Defendant-Appellant.



         A PPE AL FR OM T HE UNITED STATES DISTRICT COURT
                  FOR T HE D ISTRICT OF NEW M EXICO
                       (D .C . NO. CR-04-1348-M CA)


Robert J. Gorence, Gorence & Oliveros, P.C., Albuquerque, New M exico, for
Defendant-Appellant.

David N. W illiams, Assistant United States Attorney (David C. Iglesias, United
States A ttorney, and Laura Fashing, Assistant United States A ttorney, with him
on the brief), Office of the United States Attorney, Albuquerque, New M exico,
for Plaintiff-Appellee.


Before H E N RY, SE YM OU R, and TYM KOVICH, Circuit Judges.


T YM K O VIC H, Circuit Judge.


      Gilbert Herrera was convicted of conspiring to traffic cocaine after a four-

day jury trial. Four months after his conviction, Herrera filed a motion for a new
trial claiming newly discovered evidence would show that he had not been

competent during trial. The motion contended that the cognitive effects of acute

diabetes combined with a severe staph infection which was diagnosed only after

trial impaired Herrera’s ability to interact with counsel at trial. The district court

denied the motion without the benefit of an evidentiary hearing on competency,

concluding that no bona fide doubt existed that Herrera had in fact been

competent at trial.

      On appeal, we must decide whether the district court erred in denying the

motion for new trial w ithout first conducting an evidentiary hearing. W e hold

that the district court did not abuse its discretion, and therefore AFFIRM .

                                   I. Background

      After nearly a four-year investigation conducted by the Federal Bureau of

Investigation, the government charged Gilbert Herrera, along with his brother-in-

law , Louis Chavez, with conspiracy to distribute 500 grams or more of cocaine in

violation of 21 U.S.C. §§ 841(a)(1), (b)(1)(B) and 846. Herrera and Chavez were

tried together before a jury beginning on November 9, 2004. After several

witnesses testified against the two, including a Herrera family friend, a jury found

them guilty of the charges on November 15, 2004.

      Four months later Herrera filed a motion for a new trial pursuant to Rule 33

of the Federal Rules of Criminal Procedure on the basis of newly discovered

evidence that he was not competent to stand trial. Specifically, Herrera claimed

                                           2
he was diagnosed with adult diabetes on November 16, 2004, the day after his

trial ended. Herrera contended that the previously undiagnosed and untreated

diabetes coupled with a staph infection afflicting his lower body and extremities

during trial rendered him unable to understand the legal proceedings against him

or to ably assist his attorney.

       A summary of medical records from his detention facility indicates that

Herrera suffered from and was treated for a highly contagious and difficult to

treat bacterial infection in the months leading up to trial. On September 7, 2004,

Herrera complained of a foot wound, which was treated with an anti-fungal cream

and antibiotic. Then on October 14, 2004, Herrera complained of foot pain and

requested inserts for his shoes. M edical personnel again gave him an anti-fungal

cream on November 3, 2004 for a bad rash on his legs. Nothing in the record

indicates Herrera received any medications that could have impaired his cognitive

abilities.

       On the day before his trial began, Herrera made a sick call complaining, “I

am bleeding all over the place. I need to be seen ASA P. I will be in trial

tomorrow on 11/15/04. And I will advise my law yer Robert Gorence about this

problem. I am in Bad Pain. I need to be seen when I get back.” I Aplt. App. at

39. On November 16, 2004, the day after the trial concluded, medical personnel

noted Herrera’s complaint of “red spots on arms and buttocks” and observed that




                                          3
the skin on his left forearm and buttocks was “red, swollen and tender.” Id. H e

was administered an antibiotic for the skin infection.

      At the November 16 visit, a physician for the detention facility formally

diagnosed Herrera with diabetes and prescribed a diabetic medication and diet to

control his blood-glucose levels. Before that date, the summary indicates that

medical personnel had begun to administer tests to determine Herrera’s blood-

glucose levels, and diabetes was listed as a potential diagnosis as early as August

18, 2004. The tests indicated that Herrera’s blood sugar level in the four months

preceding trial averaged 234, where the normal range is 70-109. Before his

November 16 diagnosis, Herrera received no treatment for his diabetes.

      In an affidavit supporting his Rule 33 motion, Herrera claimed he felt

“faint, nauseous, and for the most part delirious” at trial. Id. at 43. He argues

that his undiagnosed diabetes exacerbated the problems. For example, he claims

he ate many candy bars leading up to his trial because of stress.

      In addition, Herrera affirmed,

      [T]he sores on my body were so painful that I had trouble
      concentrating on issues during the trial to any degree whatsoever.
      . . . As much as I tried to overcome my medical problems during
      trial, I did not have the ability to understand the evidence
      presented at trial, nor did I have the ability to understand the
      legal issues presented at trial. . . . I now understand that I was
      not capable of assisting my attorney in my defense during the
      trial.

Id.



                                          4
      Herrera’s defense counsel also included an affidavit in support of the Rule

33 motion. Counsel stated that Herrera reported various complaints about his

health. Counsel further observed that Herrera seemed “lackadaisical and

different” at the trial, and that he had a “very difficult time communicating with

M r. Herrera during the trial because of his listlessness and inability to

concentrate.” Id. at 55–56. In hindsight, counsel believed that Herrera was not

capable of assisting him effectively because of the cognitive deficits associated

with Herrera’s medical condition during trial.

      Herrera also provided the curriculum vitae of David H. Goldstein, M .D., a

physician and medical consultant. Although Dr. Goldstein did not personally

examine Herrera, counsel indicated that the doctor could opine generally to the

cognitive manifestations of the onset of acute diabetes, magnified by a staph

infection. According to Herrera’s motion papers, the combination of medical

conditions could cause “cognitive deficits related to a lack of concentration and

diminished mental functioning.” Id. at 53.

      The government opposed the motion claiming that Herrera exhibited no

irrational or bizarre demeanor or any signs of physical illness during the trial.

The government noted that Herrera and his counsel failed to communicate his

medical condition to the district court. Furthermore, the government argued that

the district court had no jurisdiction over the motion since Herrera’s complaint

did not involve newly discovered evidence.

                                           5
         The district court denied Herrera’s motion for a new trial without holding

an evidentiary hearing. Herrera was sentenced to prison for 120 months followed

by a supervised release term of eight years.

                                       II. Analysis

         Herrera’s central claim is that the district court erred in denying his motion

for a new trial on the basis of newly discovered evidence without first conducting

an evidentiary hearing. Herrera contends that his post-trial diagnosis of acute

adult diabetes constitutes newly discovered evidence of his incompetence to stand

trial.   He also claims the district court should have granted a mistrial after it

admitted hearsay evidence in violation of his Sixth A mendment rights.

         A.    M otion to G rant a New Trial

         Rule 33 authorizes trial courts to grant new trials “if the interest of justice

so requires.” Fed. R. Crim. P. 33(a). A motion for a new trial is not regarded

with favor and is only issued with great caution. United States v. Trujillo, 136

F.3d 1388, 1394 (10th Cir. 1998). W e ordinarily review the denial of a new trial

for abuse of discretion. United States v. Quintanilla, 193 F.3d 1139, 1146 (10th

Cir. 1999). “A decision is an abuse of discretion only if it is arbitrary, capricious,

whimsical, or manifestly unreasonable.” United States v. Combs, 267 F.3d 1167,

1176 (10th Cir. 2001) (internal quotes omitted).

         M otions for new trial filed more than seven days after a verdict or a finding

of guilt must be grounded on newly discovered evidence. Fed. R. Crim. P. 33(b).

                                             6
Since Herrera filed this motion four months after trial, newly discovered evidence

is the only ground available to Herrera for a new trial. For Herrera to prevail on a

motion for a new trial based on newly discovered evidence, he must show that:

       (1) the evidence was discovered after trial; (2) the failure to learn
       of the evidence was not caused by his own lack of diligence; (3)
       the new evidence is not merely impeaching; (4) the new evidence
       is material to the principal issues involved; and (5) the new
       evidence is of such a nature that in a new trial it would probably
       produce an acquittal.

United States v. Sinclair, 109 F.3d 1527, 1531 (10th Cir. 1997) (internal quotes

omitted).

      In this case, Herrera’s newly discovered evidence does not bear on the

probability of his acquittal, but rather on his competence to stand trial. “It has

long been accepted that a person whose mental condition is such that he lacks the

capacity to understand the nature and object of the proceedings against him, to

consult with counsel, and to assist in preparing his defense may not be subjected

to a trial.” Drope v. Missouri, 420 U.S. 162, 171 (1975). Thus, “where the newly

discovered evidence pertains not to the defendant’s guilt, but to his competency to

stand trial,” the relevant inquiry is whether the new evidence indicates that the

defendant did not have “‘sufficient . . . [present] ability to consult with his lawyer

with a reasonable degree of rational understanding’ and ‘rational as well as

factual understanding of the proceedings against him.’” United States v.

M cCarthy, 54 F.3d 51, 55 (2d. Cir. 1995) (quoting Dusky v. United States, 362



                                           7
U.S. 402, 402 (1960)); see also M aynard v. Boone, 468 F.3d 665, 676 (10th Cir.

2006).

         The district court denied the motion for two reasons: (1) the evidence was

not newly discovered; and (2) Herrera did not raise a bona fide doubt he was

incompetent during trial. W e agree with both conclusions.

         1. The Evidence Was Not Newly Discovered.

         The district court denied the Rule 33 motion on the ground that Herrera

failed to show that the evidence in question was “newly discovered” after trial.

W hile H errera’s specific diagnosis of diabetes was made a day or two after trial,

the district court concluded that the symptoms or physical manifestations of the

illness, rather than its formal diagnosis by a physician, formed the basis for his

competency claim. The district court held that such symptoms or physical

manifestations do not qualify as “newly discovered evidence” for purposes of

Rule 33.

         According to the record, Herrera was aware of the symptoms of his medical

condition prior to trial. The district court found that Herrera had consulted a

doctor before trial and had advised his trial counsel of various health problems

both before and during trial. Indeed, doctors suspected Herrera suffered from

diabetes as early as August of 2004, well before trial. W hat Herrera did not know

was the formal diagnosis of his diabetes. And, in at least one post-trial medical




                                           8
opinion, a doctor suggested to trial counsel that the untreated diabetes coupled

with his staph infection could have some effect on a person’s cognitive abilities.

      Nonetheless, the district court was satisfied that Herrera (while not

knowing the precise diagnosis) was well-aware during trial that he was

experiencing certain physical symptoms. Those symptoms w ere communicated to

his lawyer, who concluded they were not serious enough to advise the court. The

district court, moreover, saw nothing in Herrera’s demeanor and behavior at trial

to suggest that he could not consult with his trial counsel or understand the

proceedings against him. In these circumstances, the diagnosis of his medical

condition does not constitute new evidence justifying a new trial.

      This is not to say that a post-trial diagnosis of a serious medical condition

cannot satisfy Rule 33. Several cases suggest that diagnoses made available only

after trial could in some circumstances form a basis for a new trial, even where

the symptoms were known or knowable during trial. See, e.g., Nagell v. United

States, 354 F.2d 441 (5th Cir. 1966) (holding that a previously unknown brain

injury the defendant suffered more than ten years prior is newly discovered

evidence of his competence even though defendant knew about the injury); United

States v. M assa, 804 F.2d 1020, 1022–23 (8th Cir. 1986) (disagreeing with a

district court holding that a post-trial psychiatric assessment could not be newly

discovered evidence because the factual circumstances supporting the evaluation

were known to defendant at trial); United States v. Escobar, 68 F.App’x. 836 (9th

                                          9
Cir. 2003) (finding that a post-trial re-evaluation of defendant’s intelligence could

be newly discovered evidence); Smith v. United States, 1993 U.S. App. LEXIS

14520 (7th Cir. June 14, 1993) (deciding that an after trial diagnosis of “possible

paranoid schizophrenia” could be newly discovered evidence, even though motion

was rejected on other grounds).

      These cases, of course, involve serious mental conditions and not physical

infirmities that might affect the defendant’s ability to assist counsel. Suffice it to

say that the evidence must firmly point to a serious mental or physical condition

that affected the competency of the defendant at trial to assist in his defense.

      Here, given (1) Herrera’s knowledge of his physical symptoms prior to or

during trial, and (2) the lack of any suggestion at trial from counsel or the

defendant that he could not understand the proceedings, the district court

correctly concluded that the post-trial diagnosis that Herrera suffered from

diabetes and a staph infection did not qualify as newly discovered evidence under

Rule 33.

      2. Herrera Did Not Raise a Bona Fide Doubt of Competency at Trial.

      Even if the evidence were newly discovered, the district court also found

that the totality of the circumstances “do[es] not raise a bona fide doubt or

support a reasonable inference that [Herrera] was not competent to stand trial” in

November 2004. I Aplt. App. at 82. Herrera contends that the district court erred




                                          10
in reaching this conclusion without the benefit of an evidentiary hearing. W e

disagree.

      A claim complaining of “a trial court’s alleged failure to hold a competency

hearing” is a procedural due process claim. M cGregor v. Gibson, 248 F.3d 946,

952 (10th Cir. 2001). A violation of a procedural competency claim occurs when

a “reasonable judge should have had a bona fide doubt as to [the defendant’s]

competence at the time of trial” and no further competency inquiry was afforded

the defendant. Id. at 954; see also Pate v. Robinson, 383 U.S. 375, 385 (1966). 1

Accordingly, Herrera would have been entitled to an evidentiary hearing on his

motion for a new trial if his motion papers raised a “bona fide doubt” about his

competence at the time of trial. The district court concluded that Herrera failed to

show a contemporaneous inability to communicate with counsel at trial.

      The well-settled legal standard for assessing competency is that the

defendant must have “sufficient present ability to consult with his lawyer with a

reasonable degree of rational understanding [and have] a rational as well as

factual understanding of the proceedings against him.” Dusky, 362 U.S. at 402. In



      1
          Herrera also raises a substantive due process claim on appeal. “[A]
substantive competency claim is founded on the allegation that an individual was
tried and convicted while, in fact, incompetent.” M cGregor, 248 F.3d at 952.
Since we conclude no bona fide doubt exists that Herrera was not incompetent at
trial, he likewise fails to make a substantive due process claim. See Walker v.
Gibson, 228 F.3d 1217, 1230 (10th Cir. 2000) (W here a petitioner cannot show a
bona fide doubt as to his competency, “he cannot meet the more stringent
substantive due process competency standard.”).

                                         11
determining whether “bona fide doubt” of competence exists, courts may look to

the defendant’s “irrational behavior,” “demeanor at trial,” “any prior medical

opinion[,]” “evidence of mental illness[,]” and “any representations of defense

counsel[.]” M cGregor, 248 F.3d at 954–55. “W e examine the totality of the

circumstances . . . . The question is . . . whether the trial court ‘failed to give

proper weight to the information suggesting incompetence which came to light

during trial.’” Id. at 955 (quoting Drope, 420 U.S. at 179).

      W ith these standards in mind, we turn to the district court’s determination

that Herrera failed to raise a “bona fide doubt” as to his competence at trial. The

district court first found the documents supporting his motion for a new trial were

not credible. For example, H errera’s affidavit claimed that he felt “faint,

nauseous, and . . . delirious” during the trial, but neither Herrera nor his counsel

alerted the court to any health concerns during trial nor were these conditions

reflected in the summary of his medical records. In fact, Herrera specifically

asserted his right to a speedy trial and did not seek a continuance of his trial

based on his medical condition. Herrera failed to offer any explanation as to why

he was unable to communicate these health complaints to his counsel or the court.

      Furthermore, we find no fault with the district court’s assessment of

Herrera’s demeanor at trial. The district court did not notice anything unusual in

Herrera’s demeanor or behavior during trial, which Herrera concedes on appeal.

The district court observed no signs that Herrera was inattentive, bleeding, faint,

                                            12
nauseous, delirious, lackadaisical, or otherwise in distress. On the other hand, the

court found Herrera appeared to communicate with his counsel and attend to the

proceedings in a normal manner during the entire trial. In addition, there was

nothing out of the ordinary or unusually strenuous in the proceeding of the trial.

The district court allowed breaks at regular intervals and Herrera enjoyed several

days off trial for a holiday and weekend.

      Nor does the proffer of Dr. Goldstein w arrant a different conclusion. Dr.

Goldstein’s curriculum vitae indicates he is board-certified in pulmonary and

internal medicine, but nothing suggests he has medical expertise in diabetes or

mental health in general. M oreover, Dr. Goldstein never personally examined

Herrera, but intended to present testimony of general conclusions about possible

cognitive deficits associated with diabetes and a staph infection. The medical

personnel who actually did examine Herrera prior to trial made no note of any

mental infirmities or cognitive deficiencies in his medical records.

      Finally, we consider trial counsel’s affidavit describing Herrera’s medical

conditions during trial and his post hoc determination that Herrera was unable to

assist counsel effectively during trial. Understandably, “defense counsel is often

in the best position to determine whether a defendant’s competency is

questionable.” M cGregor, 248 F.3d at 960. Nevertheless, “the concerns of

counsel alone are insufficient to establish doubt of a defendant’s competency.”

Id. at 959–60. W hile important evidence, those concerns must be w eighed against

                                            13
the ability of the district court to assess the behavior of the defendant at trial.

W hen coupled with the fact that no doctor opined that Herrera was incompetent

before or even during trial, we see no clear error in the district court’s ruling.

Indeed, the behavior of Herrera was not significant enough for experienced trial

counsel to advise the court during trial proceedings of any inability to effectively

represent his client. Nor has counsel pointed to anything specific at trial that

Herrera did not understand or could not review , only that the confluence of events

raised concerns about Herrera’s condition. See Walker v. AG, 167 F.3d 1339,

1346–47 (10th Cir. 1999) (rejecting petitioner’s procedural incompetency claim,

in part because trial counsel never raised the issue of petitioner’s competency at

trial).

          In sum, we do not find the district court “ignored evidence that, viewed

objectively, raised a bona fide doubt as to [defendant’s] competency.” Clayton v.

Gibson, 199 F.3d 1162, 1171 (10th Cir. 1999) (internal quote omitted). Even if

Herrera’s post-trial diagnosis with diabetes is properly “newly discovered

evidence” under Rule 33, it would not alter the district court’s calculation that no

bona fide doubt existed as to his competency. 2




          2
       For the same reasons, the district court did not err by failing to order a
competency hearing under 18 U.S.C. § 4241(a) (district court may order a
competency hearing if given “reasonable cause” to doubt defendant’s
competence).

                                            14
      Accordingly, the district court did not abuse its discretion in denying

Herrera’s motion for a new trial without the benefit of an evidentiary hearing on

competency.

      B.      M otion to G rant a M istrial

      At trial, a government agent offered limited testimony of information he

obtained by listening to radio surveillance during a controlled narcotics buy. The

testimony placed Herrera at the scene of the buy. Herrera contends that the

district court erred by denying his motion to grant a mistrial after the court

allowed this hearsay testimony in violation of his Sixth Amendment right to

confront his accusers. This claim is the same argument made by a co-defendant

in United States v. Chavez, 05-2209.

      In Chavez, we concluded that the admission of the evidence w as harmless

error since (1) substantial eyewitness evidence at trial disclosed that the

defendants, including Herrera, dealt drugs; (2) the FBI captured many of the

transactions on tape; (3) the testimony was of limited value to the case as a whole

in light of the eyewitness testimony; and (4) the trial court provided a curative

instruction immediately follow ing the hearsay testimony. For the same reasons,

we agree that any error was harmless as to Herrera.

      Accordingly, we incorporate our holding in Chavez on this issue and affirm

the district court’s denial of the motion for mistrial.




                                          15
                                 III.Conclusion

      For the foregoing reasons, we AFFIRM Herrera’s conviction and the denial

of his motion for a new trial.




                                       16